Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tethys tethers Lipomics

This article was originally published in The Gray Sheet

Executive Summary

Diagnostics start-up Tethys Bioscience acquires Lipomics Technologies Sept. 17 for an undisclosed sum to shore up its technology know-how to create new tests beyond its first diabetes risk assessment tool, launched earlier this year. Tethys' PreDx test, which measures levels of several proteins in a patient's blood to calculate a score identifying their risk for developing diabetes, relies on the firm's expertise with protein biomarkers. Lipomics, on the other hand, specializes in profiling lipids, which can be evaluated in combination with proteins as an effective risk assessment tool for chronic conditions, Tethys says. Lipomics' current business centers on contracting to perform biomarker research for drug company development projects, partnerships that could be helpful to Tethys' plan to establish drug-diagnostic co-marketing agreements (1"The Gray Sheet" July 28, 2008, p. 16)
Advertisement

Related Content

Tethys Builds A Case For Pre-Diabetes Algorithm-Based Screening
Tethys Builds A Case For Pre-Diabetes Algorithm-Based Screening
Advertisement
UsernamePublicRestriction

Register

MT026602

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel